SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001903596-23-000145
Filing Date
2023-02-21
Accepted
2023-02-17 18:24:57
Documents
15
Period of Report
2023-02-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 kays_8k.htm   iXBRL 8-K 28857
2 KAYA HOLDINGS, INC. PSYCHEDELICS SUBSIDIARY TAPS TOTAL HOLISTIC CENTER TO DEVELO ex99_1.htm EX-99.1 28560
3 GRAPHIC image_001.jpg GRAPHIC 9732
4 GRAPHIC image_002.jpg GRAPHIC 17127
  Complete submission text file 0001903596-23-000145.txt   272741

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE kays-20230215.xsd EX-101.SCH 3239
6 XBRL LABEL FILE kays-20230215_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE kays-20230215_pre.xml EX-101.PRE 22367
9 EXTRACTED XBRL INSTANCE DOCUMENT kays_8k_htm.xml XML 3399
Mailing Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304
Business Address 915 MIDDLE RIVER DRIVE, SUITE 316 FORT LAUDERDALE FL 33304 954-5347895
Kaya Holdings, Inc. (Filer) CIK: 0001530746 (see all company filings)

IRS No.: 900898007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-177532 | Film No.: 23644498
SIC: 2834 Pharmaceutical Preparations